DeutschNewstral
Article
Bbarrons.com on 2021-12-10 17:17
Moderna Stock Drops as Flu-Vaccine Data Disappoints3 min read
Related news
- BModerna Cancer Vaccine Reduces Deaths in Trial3 min readbarrons.com
- BModerna Earnings Hit by Falling Covid Vaccine Sales1 min readbarrons.com
- BModerna Targets Fall 2023 for Covid-Flu Combo Vaccine2 min readbarrons.com
- BModerna Stock Drops. The Omicron Picture Is Getting Slightly Less Hazy. 4 min readbarrons.com
- BModerna Announces Positive Data on Covid-19 Vaccine in Children2 min readbarrons.com
- BModerna Says Vaccine for Omicron Variant Could Be Ready in Early 20222 min readbarrons.com
- BModerna Unveils Experimental Two-in-One Vaccine for Covid and the Flu2 min readbarrons.com
- BFDA Advisors Back Moderna Covid-19 Vaccine for 6- to 17-Year-Olds3 min readbarrons.com
- BModerna Surpasses Covid-19 Vaccine Sales Estimates. Why The Stock Didn't Rally. 1 min readbarrons.com
- BPfizer and Moderna Take Different Paths as Vaccine Boom Ends4 min readbarrons.com
- BModerna Earnings Hit by Falling Covid Vaccine Sales. Stock Slides.1 min readbarrons.com
- BModerna Stock Falls on Report FDA Delays Clearing Its Vaccine for Adolescents1 min readbarrons.com
- BModerna Delays Some Covid Vaccine Dose Deliveries to EU1 min readbarrons.com
- BModerna Will Open Its First Overseas Vaccine Plant In Canada2 min readbarrons.com
- BModerna Plans Two-in-One Vaccine for Covid and the Flu2 min readbarrons.com
- BModerna Confirms Covax Turned Down More Covid-19 Vaccine Doses3 min readbarrons.com
- BModerna CEO Resets Flu-Vaccine Expectations3 min readbarrons.com
- BModerna New Booster Works Against Covid-19 Variants. This Analyst Sees Future Drivers for Vaccine Maker.2 min readbarrons.com
- BModerna Stock Soared on Good News About Cancer Vaccine. Why One Analyst Downgraded the Stock.1 min readbarrons.com
- MModerna to invest $500 million in 'state-of-the-art' mRNA vaccine factory in Africa1 min readmarketwatch.com